Get the Stockscreener App
7.48
2.82%
0.205
Profound Medical Corp stock is traded at $7.48, with a volume of 48,257.
It is up +2.82% in the last 24 hours and up +9.68% over the past month.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
See More
Previous Close:
$7.275
Open:
$7.29
24h Volume:
48,257
Relative Volume:
0.28
Market Cap:
$271.47M
Revenue:
$8.98M
Net Income/Loss:
$-31.39M
P/E Ratio:
-5.5821
EPS:
-1.34
Net Cash Flow:
$-24.83M
1W Performance:
+1.08%
1M Performance:
+9.68%
6M Performance:
+69.23%
1Y Performance:
+5.06%
1-Day Range:
$7.15
$7.57
1-Week Range:
$7.05
$7.99
52-Week Range:
$3.76
$8.95
Profound Medical Corp Stock (PROF) Company Profile
Name
Profound Medical Corp
Sector
Industry
Phone
647-476-1350
Address
2400 SKYMARK AVENUE, UNIT 6, MISSISSAUGA, ON
Compare PROF vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PROF
Profound Medical Corp
|
7.48 | 264.03M | 8.98M | -31.39M | -24.83M | -1.34 |
|
ABT
Abbott Laboratories
|
113.10 | 197.42B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
381.89 | 147.18B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
95.60 | 124.16B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
72.21 | 109.58B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
85.22 | 49.49B | 6.07B | 1.06B | 1.34B | 1.8063 |
Profound Medical Corp Stock (PROF) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-23-24 | Initiated | Lake Street | Buy |
| Jul-16-24 | Upgrade | Stifel | Hold → Buy |
| Nov-28-23 | Initiated | Stifel | Hold |
| Aug-04-23 | Downgrade | Raymond James | Strong Buy → Outperform |
| Mar-21-23 | Downgrade | Jefferies | Buy → Hold |
| Sep-15-20 | Initiated | Jefferies | Buy |
View All
Profound Medical Corp Stock (PROF) Latest News
Profound Medical $PROF Shares Purchased by First Eagle Investment Management LLC - MarketBeat
Profound Medical's Earnings: A Preview - Benzinga
Profound Medical Corp (PROF) Q4 2025 Earnings Report Preview: Wh - GuruFocus
(PRN) On The My Stocks Page (PRN:CA) - Stock Traders Daily
Earnings Preview: Profound Medical (PROF) Q4 Earnings Expected to Decline - Finviz
Profound Medical (PROF) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Risk Hedge: What is the Moat Score of NYXHEntry Point & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Tech Rally: What hedge funds are buying Profound Medical CorpPortfolio Growth Summary & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Energy Moves: Can Affimed NV outperform under higher oil pricesInsider Selling & Weekly Consistent Profit Watchlists - baoquankhu1.vn
(PRN) Risk-Controlled Trading Report (PRN:CA) - Stock Traders Daily
Certain stock options of Profound Medical Corp. are subject to a Lock-Up Agreement Ending on 22-FEB-2026. - marketscreener.com
Is Profound Medical Corp. trading at a discountPortfolio Profit Report & Daily Stock Momentum Reports - mfd.ru
Profound Medical (TSE:PRN) Stock Price Up 2.6%What's Next? - MarketBeat
Profound Medical launches up to $40 million equity financing to support growth - MSN
(PRN) Strategic Market Analysis (PRN:CA) - Stock Traders Daily
Buy Signal: How does Profound Medical Corp perform in inflationary periods2025 Performance Recap & Community Driven Trade Alerts - baoquankhu1.vn
What margin trends mean for Profound Medical Corp. stockChart Signals & Accurate Trade Setup Notifications - mfd.ru
(PRN) Strategic Investment Guide (PRN:CA) - Stock Traders Daily
Profound Medical to Release Fourth Quarter and Full Year 2025 Financial Results on March 5th Conference Call to Follow - marketscreener.com
Risks Still Elevated At These Prices As Profound Medical Corp. (TSE:PRN) Shares Dive 27% - simplywall.st
Profound Medical Schedules Q4 and 2025 Results Call - TipRanks
Profound Medical to Release Fourth Quarter and Full Year 2025 Financial Results on March 5th – Conference Call to Follow - marketscreener.com
Profound Medical Honored with INOVAIT's 2025-2026 Mount Logan Award Recognizing the TULSA Procedure for Prostate Disease - Investing News Network
Profound Medical Earns INOVAIT Award, Accelerates TULSA Expansion - TipRanks
Profound Medical Honored with INOVAIT’s 2025-2026 Mount Logan Award Recognizing the TULSA Procedure™ for Prostate Disease - The Manila Times
Profound Medical Corp Receives 2025-2026 Mount Logan Award - TradingView
New prostate treatment earns Canadian tech its Mount Logan prize - Stock Titan
Profound Medical Honored with INOVAIT’s 2025–2026 Mount Logan Award Recognizing the TULSA Procedure™ for Prostate Disease - Yahoo Finance
(PRN) Strategic Equity Report (PRN:CA) - Stock Traders Daily
Aug Sectors: Is Profound Medical Corp in a bullish channelWatch List & Consistent Income Trade Ideas - baoquankhu1.vn
Profound Medical Corp.'s (TSE:PRN) market cap dropped CA$42m last week; individual investors who hold 56% were hit as were institutions - simplywall.st
Profound Medical (PROF) Celebrates Milestone in Poland with 500t - GuruFocus
PRO FAMILIA and Profound Medical Celebrate 500 Sonalleve® Procedures, Expanding Access to Incision-Free Care for Women's Health - Investing News Network
Profound Medical Marks 500th Sonalleve Procedure Milestone - TipRanks
Profound Medical Corp Celebrates 500th Sonalleve® Procedure at PRO FAMILIA - TradingView
PRO FAMILIA and Profound Medical Celebrate 500 Sonalleve® Procedures, Expanding Access to Incision-Free Care for Women’s Health - The Manila Times
500 incision-free uterine treatments completed at Polish hospital - Stock Titan
Death Cross: What hedge funds are buying Profound Medical CorpBull Run & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Market Outlook: Is LBRDK in a consolidation phaseWeekly Stock Summary & Long-Term Investment Growth Plans - baoquankhu1.vn
Analyzing Profound Medical (NASDAQ:PROF) & Reviva Pharmaceuticals (NASDAQ:RVPH) - Defense World
Opinion: This Is the Only TSX Growth Stock to Own for the Next 3 Years - Yahoo! Finance Canada
Profound Medical (NASDAQ:PROF) Shares Down 1.3% – Should You Sell? - Defense World
Profound Medical to Engage Investors at February Life Sciences Conferences - TipRanks
Profound Medical Corp Announces Upcoming Investor Events - TradingView
Profound Medical Announces Upcoming Investor Events - The Manila Times
How To Trade (PRN) (PRN:CA) - Stock Traders Daily
Johns Hopkins Medicine Initiates Use of Profound Medical’s TULSA-PRO System - Medical Product Outsourcing
(PROF) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Profound Medical raises US$6.45 million in Canadian private placement - MSN
Profound Medical’s TULSA-PRO marks first commercial case at Johns Hopkins - MSN
(PRN) Daily Stock Insights (PRN:CA) - Stock Traders Daily
Profound Medical Corp Stock (PROF) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.27%
1.94%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):